Rapport Therapeutics, Inc. RAPP

33.91 0.08 0.24% as of 25 Sep
Market cap
$1.6B
P/E
0.0×

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
31.16 147.56 305.39 490.64
Total current assets
31.27 150.87 309.80 498.56
Property, Plant, Equpment (Net)
0.34 1.92 3.53 2.98
Long-term assets (Other)
— 0.55 0.16 0.99
Total non-current assets
0.34 4.55 5.13 13.87
Total Assets
31.60 155.42 314.93 512.43
Accounts Payable
1.45 2.50 1.95 4.19
Accrued Expenses
0.21 5.63 6.08 12.10
Total current liabilities
1.66 8.80 8.77 19.05
Liabilities (Preferred Stock)
10.44 4.20 — —
Total non-current liabilities
10.44 5.68 0.74 8.73
Total liabilities
12.10 14.48 9.51 27.78
Additional Paid In Capital
0.59 19.80 429.66 719.29
Preferred Stock (Total)
29.57 166.58 — —
Common Stock (Net)
0.00 0.00 0.04 0.05
Retained Earnings
(10.65) (45.44) (123.74) (235.23)
Common Equity (Total)
(10.06) (25.63) 305.43 484.65
Shareholders Equity (Total)
19.51 140.94 305.43 484.65
Shareholders Equity and Liabilities (Total)
31.60 155.42 314.93 512.43
Shares (Common)
3.59 4.17 36.58 47.77
Shares (Preferred)
40.18 151.46 0.00 —
Shareholders Equity (Tangible)
19.51 140.94 305.43 484.65
Net Debt
(31.16) (147.56) (305.38) (490.64)

Fold the line items

In millions of $ except per-share values · columns are period end dates